[Forwarded from COVID-19 Up]
"Why the Rush for Toddler Vaccines?" Asks Wall Street Journal Editorial Board Member

???@COVID19Up: A Wall Street Journal (WSJ) editorial board member Monday (July 4) called (https://www.wsj.com/articles/w....hy-the-rush-for-todd question the motives behind the U.S. FDA's decision (https://www.cnn.com/2022/06/17..../health/fda-vaccine- to extend Emergency Use Authorization of Pfizer and Moderna’s COVID-19 vaccines to toddlers and infants as young as 6 months old.

In her WSJ opinion piece—“Why the Rush for Toddler Vaccines?”—Allysia Finley wrote:

“The FDA standard for approving vaccines in otherwise healthy people, especially children, is supposed to be higher than for drugs that treat the sick. But the FDA conspicuously lowered its standards to approve COVID vaccines for toddlers. Why?”

Finley started her piece with a quote from President Biden, which praised the FDA’s recommendation: “This is a very historic milestone. The United States is now the first country in the world to offer safe and effective COVID-19 vaccines for children as young as six months old.”

She responded, writing, “In fact, we don’t know if the vaccines are safe and effective.”

“The rushed FDA action was based on extremely weak evidence. It’s one thing to show regulatory flexibility during an emergency. But for children, Covid isn’t an emergency. The FDA bent its standards to an unusual degree and brushed aside troubling evidence that warrants more investigation.”

As to why the FDA “rushed” and “bent its standards,” Finley suggested, “perhaps [the FDA] felt pressure from the White House as well as anxious parents.”

Join the discussion:
➔ ?@COVID1984chat